Volume 33, Issue 227 (12-2023)
J Mazandaran Univ Med Sci 2023, 33(227): 134-139 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mousavi T, Emadi N, Barimani S, Kazeminejad A. Serum Selenium Level in Patients with Genital Warts Compared to Healthy Individuals. J Mazandaran Univ Med Sci 2023; 33 (227) :134-139
URL: http://jmums.mazums.ac.ir/article-1-20223-en.html
URL: http://jmums.mazums.ac.ir/article-1-20223-en.html
Abstract: (1889 Views)
Background and purpose: Selenium, a rare and essential element, is crucial in various skin diseases. Given its significance, this study aimed to investigate the serum selenium levels in patients with genital warts and compare them with those of healthy individuals.
Materials and methods: This case-control study involved 40 patients with genital warts and 40 healthy individuals. Serum selenium levels were measured using a Calbiotech laboratory kit with two cc of intravenous blood samples. Demographic characteristics and disease-related factors, including disease duration, severity of genital warts, and areas of skin involvement, were recorded. Data were analyzed using SPSS software version 20.
Results: In the case group, the average age was 30.68±9.38 years, and in the control group, it was 34.30±6.90 years (P=0.060). The mean serum selenium level in the case group was lower than in the control group (83.92±35.43 vs. 93.62±26.29 ng/ml, respectively, P=0.168). Notably, there was no statistically significant difference in serum selenium levels with age (P=0.051), gender (P=0.062), number of lesions (P=0.750), disease duration (P=0.938), disease severity (P=0.618), or areas of skin involvement (P=0.349).
Conclusion: Patients with genital warts exhibited lower serum selenium levels than their healthy counterparts, suggesting a potential correlation between weakened immune system strength and increased inflammatory conditions. Future studies are imperative to delve deeper into the immunomodulatory role of trace elements, such as selenium, in human papillomavirus infections and various skin wart types.
Materials and methods: This case-control study involved 40 patients with genital warts and 40 healthy individuals. Serum selenium levels were measured using a Calbiotech laboratory kit with two cc of intravenous blood samples. Demographic characteristics and disease-related factors, including disease duration, severity of genital warts, and areas of skin involvement, were recorded. Data were analyzed using SPSS software version 20.
Results: In the case group, the average age was 30.68±9.38 years, and in the control group, it was 34.30±6.90 years (P=0.060). The mean serum selenium level in the case group was lower than in the control group (83.92±35.43 vs. 93.62±26.29 ng/ml, respectively, P=0.168). Notably, there was no statistically significant difference in serum selenium levels with age (P=0.051), gender (P=0.062), number of lesions (P=0.750), disease duration (P=0.938), disease severity (P=0.618), or areas of skin involvement (P=0.349).
Conclusion: Patients with genital warts exhibited lower serum selenium levels than their healthy counterparts, suggesting a potential correlation between weakened immune system strength and increased inflammatory conditions. Future studies are imperative to delve deeper into the immunomodulatory role of trace elements, such as selenium, in human papillomavirus infections and various skin wart types.
Type of Study: Brief Report |
Subject:
infection
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
